FROM WHIZKNOCK whizknock Friday, 02/03/17 06:01:14

New Post Public Reply Private Reply Replies (0) Message Board
BUMPERCARS
343
FROM WHIZKNOCK

whizknock Friday, 02/03/17 06:01:14 PM

**BMXC, ARE YOU NEW? READ THIS WEEKEND!**

StockWhale has done some excellent detective work! Read his following information,,,
.................................................................
"Alright so it seems the CEO's husband works for Hygiene Products Company in Qatar that manufactures you guessed it diapers and sanitary products. Here's an investment company on Qatar that has a large investment in them description of the company:

The Company is a manufacturer of globally patented, specially designed adult diapers, sanitary napkins and baby diapers for the best fit & comfort, offering freedom of movement with high quality absorbent capacity.

www.state-holding.com/new/hygiene-products-factory/

I used the FB of the CEO and the Instagram of the company to find the link between the CEO's company and the company the husband works for that is a huge manufacturer of these speciality diapers.

It seems plausible she might have struck a deal with the company through her husband in order to actually manufacture her own diapers.

At first I thought it was a reseller website, selling products from other websites, but now I think we have something much much bigger than any of us suspected!

More DD to come."

Company website: www.hpf-qatar.com
...............................................................


Accumulation/Consolidation continues prior to next move UP!

Sometimes when things are so obvious, it's because they're exactly what they appear to be!

The CEO communicates her agenda with shareholders then updates with 8Ks to confirm she has followed through.

Some examples,,, She converts 150 million of her own shares to 50 million preferred & locks them up for a minimum of one year. Then she drops an 8K! Then another 8K Thursday to confirm the Final paperwork is in for the reduction of the O/S by the CEO!

All toxic notes have been converted & no more toxic debt is taken on. Then she drops another 8K! This appears to confirm what she told us & is all part of the plans to Up List.

No doubt we will get an 8K when she follows up on the Up Listing.

Not that we'll need it but you can bet we'll get another 8K on or around April 4th when the company begins selling on Amazon.

Now consider the implications of her last PR,,,
...................................................................

http://www.otcmarkets.com/stock/BMXC/news

Edited excerpts from the PR,,,

Tuesday, January 31 2017 10:00 AM, EST Bemax Inc. (OTCBB: BMXC), a growing global distributor of Disposable Baby Diapers, is pleased to announce today that it has received an $1.1 milion purchase order from an existing client, a major distributor of the Disposable Diaper in the emerging South and East African markets.

Taiwo Aimasiko, CEO of Bemax Inc. "The size of this purchase order clearly reaffirms the quality of our private-labels and eliminate the need for financing."
...................................................................

Those excerpts are all I needed to read.

Think about that, eliminate the need for financing!"!

Okay, maybe she's just talking about this one deal,,, But if she doesn't need financing she must be pretty damn close to CASH FLOW POSITIVE!

That implies to me that she's not real far off from reporting EARNINGS. Not revenues,,, earnings, as in actual profits!

BUT IT GETS EVEN BETTER!

Read Investingnotgambling's post,,,
..................................................................

investingnotgambling Thursday, 02/02/17 08:15:03 PM
Re: lipster post# 11601
Post # of 12034

"I said it before and I'll say it again...yes, and they already have! The $1.1 million purchase order is going to ensure no financing is needed. How huge is that?

Also, she stated, "This new purchase order resulting from the long-term supplier agreement filed on November 16, 2015 is the first tranche of purchase order in 2017, with Bethel Imports paying for each consignment before shipment by Bemax." First tranche...meaning more expected.

The revenues and positive cash flow are just beginning folks. If you're waiting for this to be uplisted or for product to be on Amazon, you're going to look back and think "why didn't I buy some shares back in January?" I'm glad I'm in big-time on this one. I along with many others here will not be the one's looking back saying "what if..."
..................................................................

OTC stocks in the penny neighborhood don't generate profits. If they did they wouldn't be trading in the pennies anymore.

I have a feeling this stock, BMXC, will not be trading down here at less than 20 cents a couple months from now,,, not long before our CEO reports the first profits.

Keep in mind that the stock has a 52 week high of a little over a dollar. At that time the stock had just a little less outstanding shares but no where near as good fundamentals that we enjoy now! Investors here agree we will not be shocked if it climbs right back to those levels.

So if you're one of the thousands that has read this in the past hour, spread the word. I'm sorry that due to space there was a ton of positive information I didn't post!

See you Monday

Bemax Inc. (BMXCD) Stock Research Links

BMXCD Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

EICMA 2026: Groundbreaking Moves in Two-Wheel World

Updated Category News Views 27

Revving Up in Milan: A Record-Breaking EICMA If you're into two-wheelers as much as stocks, EICMA 2026 is where all the action is happening. They opened the door with a bang at Fiera Milano Rho, pulling off their biggest showcase yet. Ten halls packed to the brim, up from nine the previous year, creating buzz across the globe. Showcasing 765 exhibitors and 2,142 brands...

Continue Reading
Veterinary Stories Transform Pet Care in New Docuseries

Updated Category News Views 0

Peeling Back the Scrubs: Hidden Heroes in Vet Medicine Everyone's all-hands-on-deck when it's your furball on the line, but how much do you really know about what happens in those vet offices? Finally, National Veterinary Associates (NVA) is unzipping that mystery with a no-bones-about-it docuseries, Advancing Veterinary Medicine: Our Stories, right out of Austin, Texas....

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 178

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Telespazio & Rivada Forge Secure Satellite Network

Updated Category News Views 61

Rivada's Outernet: A New Era of Connectivity Forget the terrestrial wires; we're talking about 600 satellites playing a space-age game of telephone. That's Rivada's Outernet for you, an orbital mesh network that's about to upend the very nature of global communications. Telespazio's new partnership with Rivada is like strapping a rocket onto secure connectivity in the...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 164

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 234

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 226

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 172

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 157

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Biond's BND-67 Trial: New Hope Against Tumors

Updated Category News Views 0

Turning Heads with a New Approach in Immunotherapy Right off the bat, let's say something's brewing in the world of cancer treatment, and it's got a promising name: BND-67. We're talking about Biond Biologics, an ambitious Israeli outfit aiming to rewrite the rules with their new kid on the block in immunotherapies. This isn't about business as usual. It's about a fresh...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding America's Growing Net Debtor Status: Implications Ahead

Updated Category News Views 181

Shifting Dynamics of America's Net Debtor Status By Jamie McGeever Foreign investment in the U.S. has consistently outnumbered American investments abroad for several decades. This persistent imbalance has raised concerns among analysts about potential repercussions for the dollar's confidence. Despite these warnings, the anticipated crisis regarding this dynamic has not...

Continue Reading
Understanding Doximity's Short Interest Trends and Insights

Updated Category News Views 115

Diving Deeper into Doximity's Short Interest Analysis Doximity (DOCS) has attracted attention in recent financial discussions due to its short interest metrics. Recently, it was reported that the short percent of float for Doximity has decreased by 4.22%. This decline translates to approximately 5.64 million shares sold short, constituting about 4.54% of the company’s...

Continue Reading
Explore the Future of Biologics at Apogee's R&D Day

Updated Category News Views 100

Join Apogee Therapeutics' First Virtual R&D Day Apogee Therapeutics, Inc., a promising clinical-stage biotechnology firm, is poised to present its inaugural virtual Research and Development Day. Scheduled for 10:00 a.m. ET on a soon-to-come date, this event invites those interested in the transformative work happening in the field of biotechnology. Unveiling Innovations...

Continue Reading
Empowering Education: Oklahoma City School Choice Showcase

Updated Category News Views 122

Oklahoma City School Choice Showcase Set to Inspire Families Students from around Oklahoma City are gearing up for a fantastic event at Dove Science Academy, with a heartfelt message highlighting their love for their schools. The exciting gathering will showcase K–12 school choice options available in the state, aligning perfectly with the celebratory spirit of National...

Continue Reading
Experian Uncovers Identity Fraud Trends in 2024 Global Report

Updated Category News Views 661

Comprehensive Insights from the 2024 Global Identity & Fraud Report Experian has unveiled its 2024 Global Identity & Fraud Report, delivering an in-depth analysis of consumer and business responses to prevailing fraud patterns as well as effective mitigation strategies within the financial services sector. This extensive report is backed by data accumulated from over...

Continue Reading